In contrast, there was no significant upregulation of Bbf2h7 expression in gastric or pancreatic adenocarcinomas, indicating that the gene expression of Bbf2h7 was specifically enhanced in certain tumor types. The gene discussed is CREB3L2; the disease is pancreatic adenocarcinoma.